This retrospective, institutional review boardapproved study included 125 patients with LN metastasis treated with open or laparoscopic RP and bilateral PLND by 3 of our busiest surgeons (J.A.E., B.G., and P.T.S.) over a 6-year period. Before surgery, 7 patients received radiation therapy, 5 patients received androgen deprivation therapy, and 1 patient received both therapies. FIGURE 2. A, Unifocal (left sided), large volume [total tumor volume (TTV) = 7.85 cm 3 ], high-grade tumor (black) with lymph node metastasis only on the right side. B, Multifocal (bilateral), small volume (TTV = 0.06 cm 3 ), low-grade tumor (green) with bilateral lymph node metastases. C, Anterior dominant, relatively small volume (TTV = 1.91 cm 3 ) grade 4+3 = 7 tumor with lymph node metastasis on the right side. L indicates left lobe; R, right lobe.
Abstract: Pelvic lymph node (LN) metastasis is a well-recognized route of prostate cancer spread. However, the relationship between topography and the pathologic features of primary prostatic cancers and patterns of pelvic LN metastasis has not been well studied. We reviewed original slides of radical prostatectomies and pelvic LN dissections from 125 patients with LN metastasis and recorded a total number of LN excised/ laterality of positive LN, and localization, staging parameters, lymphovascular invasion, and volume of primary tumors.
LN Quantity and Distribution: 14.6 (mean) and 13 (median) LNs were resected. Seventy-six (61%), 33 (26%), and 16 (13%) cases had 1, 2, and >2 positive LNs; whereas 58, 44, and 20 cases had LN metastasis on the right, left, and bilaterally.
Pathologic Features: Eighty-six percent (108 of 125) and 37% (46 of 125) of the cases showed extraprostatic extension and seminal vesicle invasion, whereas 64% cased showed lymphovascular invasion. Mean and median total tumor volumes were 6.39 and 3.92 cm 3 , with Z50% and Z90% Gleason patterns 4/5 in 105 (84%) and 73 (58%) cases, respectively.
Correlation With Dominant Tumor Location: Dominant lesions on radical prostatectomy were as follows: 50 right lobe, 44 left lobe, and 31 bilateral lobe tumors. Fifteen of 50 (30%) right lobe and 18 of 44 (41%) left lobe dominant tumors had LN metastasis on the contralateral side. Only 4% (5 of 125) of the cases were associated with anterior dominant tumors.
Conclusion: Thirty percent to 40% of LN metastases occurred contralateral to the dominant tumor. LN metastasis is overwhelmingly associated with high-grade, high-stage, and large volume disease. LN positivity is rarely associated with anterior dominant tumors.
Key Words: prostate, pelvic lymph node, topography, anterior tumor, lymphovascular invasion (Am J Surg Pathol 2010;34:1862-1867) P elvic lymph node dissection (PLND) is the standard means for detecting lymph node (LN) metastasis in prostate cancer. 15 Over the past 3 decades, the manner in which urologists and oncologists view the finding of LN positivity in relation to patient management has evolved. Although finding LN metastasis on frozen section analysis was once a contraindication to radical prostatectomy (RP), 12 more recent studies have recognized the curative potential of PLND. 2, 4 Over the past few years, evidence from groups such as Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), suggests a steady decline in the performance of PLND, especially for patients in low-risk and intermediate-risk groups. 15 This has coincided with the advent of risk stratification tools, which aid in selecting/avoiding intervention 8, 19 and the increasing popularity of minimally invasive surgery.
Consequently, a great variation exists in determining which risk categories warrant PLND 15 and the extent of LN sampling that should be routinely carried out. 2, 3 The latter is compounded by difficulties in determining the relationship of primary prostate cancers with the location of positive LNs, which, if known, may help govern the extent of resection. Although a number of groups 10, 12, 26, 29 have reported a variable incidence of unilateral versus contralateral LN metastasis in patients with prostate cancer, primary tumor location was assessed on digital rectal examination (DRE), transrectal ultrasound (TRUS), and/or prostatic needle biopsy (PNB) findings. Therefore, in this study, we aimed to comprehensively evaluate primary prostate cancer topography, as seen in RP specimens, and the distribution of positive LNs, to further elucidate the patterns of LN metastasis in prostate cancer.
All RP specimens were whole mounted and entirely submitted according to previously published methods. 1 Original hematoxylin and eosin (H&E)-stained slides of all cases were reevaluated by 1 of 2 genitourinary pathologists (V.E.R. and S.W.F.) and tumor maps were constructed with annotation of low-grade (Gleason pattern r3) and high-grade (Gleason pattern Z4) cancer. For each RP specimen, laterality, anterior-posterior, and apex/mid/base localization of the tumor and the presence of extraprostatic extension (EPE), seminal vesicle invasion (SVI), and lymphovascular invasion (LVI) were recorded. RP slides were scanned as 300-dpi resolution digitalized tumor maps using an Epson Perfection 4990 PHOTO digital scanner and Adobe Photoshop (version 9.0). JPEG formatted files were used to measure total tumor volume (TTV) and the percentage of high-grade tumor volume by Image-Pro Plus 5.0, with the TTV being equal to the sum of the section areas divided by 1.8797.
Frozen section analysis of LN was not carried out. All the LN specimens were fixed in 10% neutral-buffered formalin and meticulously dissected by pathologists. Five-micrometer H&E-stained sections of each paraffinembedded LN were examined microscopically. The PLND template included external iliac, obturator, and hypogastric LN bilaterally. Approximately 25% of the cases had LN submitted in 6 packets, whereas the remaining LN cases were submitted as right and left pelvic LNs. The total number of LNs and the number of positive LNs were recorded.
Student t tests were carried out to compare TTV, rate of high-grade tumor, and positive LN number between LVI-positive and LVI-negative cases. Statistical analysis was carried out using commercially available software.
RESULTS

LN Quantity and Distribution
The total number of LN dissected per case ranged from 4 to 48 (mean, 14.6; median, 13). Seventy-six of 125 (61%) cases had a single positive LN, 33 (26%) cases had 2 positive LNs, and 16 (13%) cases had more than 2 positive LNs (range, 3 to 18). Fifty-eight, 44, and 20 cases had positive LNs in the right pelvis, left pelvis, and bilateral pelves, respectively (in 3 cases laterality was unknown).
Eighty-nine cases had LN designated as "right and left pelvic," whereas 33 cases were submitted in more detailed "packets" (for 3 cases, no designation other than "pelvic" LN was provided). Among these 33 cases, LN metastases were located in the obturator, hypogastric, external iliac, periprostatic, and common iliac nodes in 16, 12, 8, 4 , and 1 cases, respectively. Fourteen of 33 cases showed positive LNs in more than 1 site and 19 cases had metastasis at a single site only [obturator (10), external iliac (5) , and hypogastric (4)].
Pathologic Features of Primary Tumors
Pathologic features for the RP specimens are detailed in Table 1 . The pathologic tumor stages were pT2, pT3a, and pT3b in 13%, 50%, and 37% of the cases, respectively. Among these, 108 (86%) cases displayed EPE and 46 cases showed SVI (45 with concomitant EPE and 1 with SVI in the absence of EPE). Tumor involved the right seminal vesicle in 17 cases, the left seminal vesicle in 12 cases, and bilateral seminal vesicles in 17 cases. Among cases without SVI, 22 of 79 (28%) cases had multiple positive LNs, compared with 27 of 46 cases (59%) with SVI (P<0.001).
Tumor Volume Studies
Mean and median TTVs were 6.39 and 3.92 cm 3 , respectively (range, 0.03 to 45.7 cm 3 ). Predominantly, high-grade tumor foci (Gleason pattern 4 to 5) accounted for Z50% of TTV in 105 (84%) cases and Z90% in 73 (58%) cases. A nearly linear relationship between TTV and the percentage of high-grade tumor was observed (results not shown).
LVI
We evaluated the presence of LVI in 115 cases in which all the original whole mount slides could be obtained. The assessment of LVI was on H&E-stained sections alone, without immunohistochemistry for endothelial markers. Care was taken to exclude retraction artifacts, tumor within prostatic ducts, and tumor within perineural spaces. We did not attempt to differentiate blood vessels from the lymphatics.
LVI was detected in 74 (64%) cases. As summarized in Table 2 , the mean number of positive LNs, TTV, and the percentage of high-grade tumor were all significantly higher in cases with LVI than in those without (P = 0.011, 0.008, and 0.013, respectively).
Correlation of Dominant Tumor Location and Positive LN Location
On review of the RP specimens, 50 dominant tumor masses were located in the right lobe, 44 in the left lobe, and 31 in bilateral lobes. Fifteen of 50 (30%) right lobedominant cases showed positive LNs on the left side (10 exclusively left and 5 bilateral LN metastases). Conversely, 18 of 44 (41%) left lobe-dominant cases showed positive LNs on the right side (9 exclusively right and 9 bilateral LN metastases) ( Figs. 1, 2) . Dominant tumors were located in the posterior/ posterolateral prostate in 102 (82%) cases, both the anterior and posterior prostate in 18 (14%) cases, and the anterior prostate only in 5 (4%) cases. Sixty dominant RP tumors extended from the apex through the base, 45 cases were located primarily in the apex to the mid-gland, and 19 cases in the mid to base. Thirteen of 16 cases without EPE or SVI (otherwise organ confined) had dominant tumors localized to the apex-mid prostate.
DISCUSSION
A number of earlier studies have attempted to determine the patterns of prostate cancer spread to LNs, reporting a 10% to 46% incidence of LN metastasis contralateral to the dominant tumor mass among LNpositive cases. 10, 12, 26, 29 As these investigations encompass different eras in the clinical application of PLND, the conclusions drawn from the data have varied. Harrison et al, 12 writing at a time when LN metastasis detected at frozen section was the cause for aborting RP, argue that as only 11 of 100 cases showed exclusively contralateral LN metastasis to DRE-detected dominant masses, ipsilateral LNs should be sampled first. Spiess et al 26 evaluated the ability of DRE, TRUS, and/or PNB to predict the side of the pelvic LN metastasis. They found a 10% to 17% rate of contralateral-only LN metastasis and false-negative predictive rates between 14% and 29% with these modalities, and they concluded that they are not accurate enough to reliably guide physicians. Similarly, Weckermann et al 29 studied 564 men with negative or unilaterally positive DRE and PNB positive in 1 lobe only, and found up to 30% contralateral-only positive LNs. Results from imaging studies are conflicting, with some reporting little "crossover" of the injected contrast medium to contralateral LNs; 24 others showing some lymphatic crossover on lymphoscintigraphy, 30 and a general consensus that standard imaging techniques consistently fail to identify the pelvic node spread with sufficient specificity. 21, 25 Given these findings, a number of researchers 10, 26, 29 have recommended complete bilateral PLND as the only appropriate LN staging method.
A drawback of earlier studies, however, is the use of surrogates (DRE, TRUS, PNB, and/or imaging findings) for the determination of the primary tumor location. To our knowledge, this is the first study to comprehensively assess prostate cancer topography, as seen in RP specimens, and corresponding LN metastasis. Here, we show that in the setting of standard (external iliac, obturator, and hypogastric) LN dissection, 15% of metastasis occurs exclusively contralateral to the dominant prostatic tumor mass. Including cases with bilateral LN metastasis, more than 25% of prostate cancers associated with positive LNs show contralateral spread. These findings are similar to those that are shown by Leissner et al, 17 who recommended extended radical lymphadenectomy to all patients undergoing radical cystectomy for bladder cancer, based on a 20% risk of contralateral LN metastasis and may suggest that a unilateral LN dissection for prostate cancer staging is unwise.
Evidence to support a therapeutic benefit of PLND in prostate cancer comes from studies showing that standard dissection (including external iliac, obturator, and hypogastric LN packets) results in detection of more positive LNs than limited (external iliac packet only) dissection, 2, 27 and others showing that the number of LN dissected correlates with time of prostate specific antigen recurrence, relapse of symptoms, and prostate cancerrelated mortality. 4 Furthermore, Burkhard et al 7 have reported that meticulous LN dissection results in a 7% rate of LN metastasis even in patients with prostate specific antigen<10 ng/mL and Gleason score <7.
Despite these data, selective application of PLND is currently the norm owing to the low reported contemporary incidence of positive LNs (2% to 6%), the rise of minimally invasive surgery, and the development of risk stratification tools to better identify the men at risk for advanced disease. 8, 11, 13, 15, 19 As highlighted by Kawakami et al 15 in their review of an observational disease registry These researchers report that although fewer overall patients underwent PLND in the 10-year period from 1992 to 2001, LN dissection was still performed in 75% and greater than 80% of low-risk and intermediate-risk patients in whom the actual incidence of LN metastasis was <1% and 2%, respectively. Importantly, they question the adequacy of PLND in achieving accurate staging, based on the small mean number of LN dissected in CaPSURE-enrolled patients. Although it is clear from these collective analyses that the application of PLND remains controversial, our median of 13 LNs dissected per case and a high incidence of positive LNs in the obturator and hypogastric LN packets (among those cases with available data), supports the contention that standard PLND yields higher LN counts and will detect more metastatic foci than dissections limited to external iliac LNs. 2, 3, 27 It is rather intuitive that the largeF6.39 cm 3 mean and 3.92 cm 3 medianFtumor volumes seen presently would be associated with pelvic LN metastasis. However, it is interesting to note that a more extensive breakdown of these data show 6%, 12%, and 26% of the cohort with <0.5, <1, and <2 cm 3 TTV, respectively. The relationship between tumor volume and pelvic LN metastasis has been explored before by McNeal, 20 who reported that the volume of Gleason patterns 4/5 cancer (ie, multiplying TTV by percentage of high-grade tumor) was most strongly predictive of LN metastasis. According to them, tumors with greater than 3.2 cm 3 Gleason grade 4/5 cancer showed a 100-fold increase in the proportion of cases with nodal spread. Although we found that predominantly Gleason grade 4/5 cancer encompassed Z50% of TTV in 84% of cases and Z90% of TTV in 58% of cases, more than half of our cohort (65 of 125; 52%) had volumes of Gleason grade 4/5 cancer <3.2 cm 3 . In a similar vein, although the majority of our cohort showed EPE, SVI, or both, 13% showed otherwise organ-confined primary tumors, the majority of which were located in the apex-mid prostate. It is apparent, therefore, that LN positivity is not uniformly associated with tumors exhibiting high TTV, large volumes of high-grade disease, or stage ZpT3a.
A remarkable finding that emerges from this topographic analysis is the small number (4%) of LN-positive cases associated with an anterior dominant tumor. Contemporary studies have shown an increasing rateFup to 20% to 25%Fof anterior dominant tumors 1, 5 and no significant difference in the rate of LN metastasis compared with posterior tumors generally. 16, 18 However, no earlier study has focused exclusively on LN-positive patients to discern these patterns. This result raises a number of interesting possibilities regarding anterior dominant tumors and PLND. First is the suggestion that anterior dominant cancers do not exhibit LN metastasis as frequently as posterior tumors. Although there is some evidence that anterior tumors are typically of lower stage because of stromal boundaries of the transition zone 20 and/or a relative paucity of nerves in the anterior prostate leading to less perineural invasion and EPE, 23, 28 this does not adequately account for the dearth of LN metastasis observed in this study. A review of the LN data from our previous report on a large series of anterior dominant tumors shows that 139 of 167 patients (97 anterior peripheral zone tumors and 70 transition zone tumors) underwent PLND (mean and median LN dissected: 10.4 and 10, respectively). Although it was not the focus of this study, we found that only 3 of 139 (2.2%) cases showed LN metastases, providing further evidence of the paucity of LN metastasis in the setting of anterior dominant tumors. 1 In this study, we also note that the mean TTV among the 5 anterior dominant tumors is 14.1 cm 3 , a value well beyond the mean TTV for all cases in this series, suggesting that only exceptionally large anterior tumors may metastasize to pelvic LNs. Another intriguing possibility is that the standard PLND performed in all of our patients does not include the main drainage pathways of the anterior prostate. Investigations of prostate lymphatic drainage have shown that removing external iliac, obturator, and hypogastric LNs covers the major regions to which the prostatic parenchyma empties, but not LN zones such as presacral nodes, which may contain a small but significant number of metastases. 6 Further study with increased limits of dissection may be necessary to determine whether anterior dominant tumors have a divergent pattern of LN drainage compared with the majority of the prostate.
Another notable feature of this analysis is the high incidence of LVI that is detected. A wide selection of RPbased studies have reported an incidence of LVI ranging from 5% to 53%; data that are confusing because of nonuniform criteria for its evaluation and marked variation in the cohorts that were studied. 9 Even with strict criteria that required unequivocal identification of tumor within endothelial-lined spaces and excluded suspicious lesions within the tumor mass, we were still able to identify LVI in 64% of patients based on H&E staining alone. LVI was noted not only in the immediate periphery of tumors but frequently in the posterior periurethral region and within/around the ejaculatory duct complex. Although statistical associations with larger TTV and volumes of high-grade tumor are similar to those reported previously, 14 the potential role of LVI in select patient groups is informative. For example, 4 of 5 anterior dominant tumors showed LVI, suggesting that intraprostatic lymphatic infiltration plays a key role in anterior tumor metastasis to LN. In addition, LVI was present in 4 of the otherwise organ-confined primary tumors with an additional 4 of these cases being among the 13 preoperatively treated cases (which might have increased the difficulty of evaluation for LVI). The association of LN metastasis in these cases with intraprostatic LVI mirrors the phenomenon of SVI in cases lacking tumor contiguous to the ejaculatory duct complex or in the periseminal vesicle extraprostatic space. 22 Finally, although the finding of multiple LN metastases in those patients with SVI was double that of patients without SVI, it is possible that the markedly different rates of LVI between these groups (83% of patients with SVI vs. 46% of patients without SVI) largely accounts for this discrepancy.
In this large, well-annotated cohort of patients with pelvic LN metastasis, we have shown that 30% to 40% of LN metastases occur contralateral to the dominant prostatic tumor mass. Moreover, although LN-positive cases are overwhelmingly associated with high-grade, high-stage, and large volume disease, subsets of patients with lower volume tumors or organ-confined primary disease may be identified in which intraparenchymal LVI likely plays a key role. LN positivity is rarely associated with anterior dominant tumors.
